| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Pyxis Oncology, Inc. (NASDAQ:PYXS) | 09/25 19:15 | prnewswire.com |
| Moment Of Truth Approaches For Pyxis Oncology | 09/13 07:08 | seekingalpha.com |
| Pyxis Oncology to Participate in Two Upcoming Investor Conferences | 08/29 07:30 | globenewswire.com |
| Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024 | 08/14 16:05 | globenewswire.com |
| Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference | 07/29 08:00 | globenewswire.com |
| Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 06/28 16:30 | globenewswire.com |
| Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger | 06/10 07:30 | globenewswire.com |
| Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference | 05/30 07:30 | globenewswire.com |
| Q2 2024 EPS Estimates for Pyxis Oncology, Inc. (NASDAQ:PYXS) Decreased by Analyst | 05/20 01:06 | https://www.defenseworld.net |
| Pyxis Oncology, Inc. (PYXS) Reports Q1 Loss, Tops Revenue Estimates | 05/14 09:41 | zacks.com |